3-(2-Bromophenyl)pyridine

Catalog No.: 
ACPLZG281
CAS No.: 
847264-30-6
Molecular Formula: 
C11H8BrN
Molecular Weight: 
234.10
3-(2-Bromophenyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$108.00In stockInquiry
1g97%$265.00In stockInquiry
5g97%$795.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(2-Bromophenyl)pyridine
IUPAC Name3-(2-bromophenyl)pyridine
MDL No.MFCD18415514
Molecular FormulaC11H8BrN
Molecular Weight234.10
SMILESBrC1=CC=CC=C1C2=CC=CN=C2
InChI KeyXEQMSSLGEYCVDC-UHFFFAOYSA-N
Synonym3-(2-bromophenyl)Pyridine;Pyridine, 3-(2-bromophenyl)-
CAS No.847264-30-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPLZG281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACPLZG281 route product structure diagram
    ACPLZG281847264-30-6In Stock
Inquiry

2. ACPLZG281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVZLK819 route compound structure diagram
    ACVZLK819583-55-1In Stock
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACPLZG281 route product structure diagram
    ACPLZG281847264-30-6In Stock
Inquiry

3. ACPLZG281 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACJTYB425 route compound structure diagram
    ACJTYB425244205-40-1In Stock
  4. Then
  5. ACPLZG281 route product structure diagram
    ACPLZG281847264-30-6In Stock
Inquiry

Comments (0)